Acantrifoside E is primarily studied for its potential anti-inflammatory and neuroprotective properties. It has shown activity in modulating signaling pathways involved in inflammation, making it a candidate for research in neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. The compound may inhibit the production of pro-inflammatory cytokines and reduce oxidative stress in neuronal cells, suggesting a role in protecting brain tissue from damage. Additionally, it is being explored for its possible anticancer effects, particularly in inhibiting the growth of certain tumor cell lines by inducing apoptosis and suppressing cell proliferation. Due to its natural origin and bioactive profile, Acantrifoside E serves as a lead compound in the development of new therapeutic agents targeting chronic inflammatory and neurological disorders.